PCC Rokita (FRA:229) Research & Development: €0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:229 PCC Rokita SA FRA:229
82 GF Score
Price €14.44
GF Value €14.86
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PCC Rokita Research & Development?

PCC Rokita FRA:229 +0.14% 82 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:229 with a GF Score™ of 82/100 and a GF Value™ of €14.86 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PCC Rokita's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

PCC Rokita  (FRA:229) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PCC Rokita Research & Development Related Terms

PCC Rokita Research & Development Historical Data

* Premium members only.

The historical data trend for PCC Rokita's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCC Rokita Research & Development Chart

PCC Rokita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PCC Rokita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:229
82GF Score
PCC Rokita SA FRA:229
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PCC Rokita Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
PCC Rokita (FRA:229) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PCC Rokita and its competitors.
Is PCC Rokita's Research & Development too high?
PCC Rokita's current Research & Development is €0.0 Mil. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's Research & Development compare to DOW?
PCC Rokita's Research & Development of €0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PCC Rokita and its competitors. PCC Rokita's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (FRA:229) is currently considered Fairly Valued. The stock's GF Value™ is €14.86, compared to a current price of €14.44 — trading 2.8% below its estimated fair value. The current Research & Development is €0.0 Mil. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PCC Rokita (FRA:229), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PCC Rokita (FRA:229) Overvalued in 2026?

Based on GuruFocus' analysis, PCC Rokita stock appears to be undervalued. The current stock price of €14.44 is trading 2.8% below its estimated GF Value™ of €14.86. GuruFocus considers PCC Rokita to be Fairly Valued.

Key valuation signals for FRA:229:

  • Research & Development: €0.0 Mil
  • GF Value™: €14.86 vs. price of €14.44 (2.8% below fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the FRA:229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PCC Rokita Business Description

Other Exchanges PCR:Poland
Address ul. Sienkiewicza 4, Brzeg Dolny, POL, 56-120
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score

Get the complete analysis for FRA:229

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.44
Price
€14.86
GF Value